Skip to main content

Table 5 Current and prior neuropathic pain treatments

From: Are treatment benefits in neuropathic pain reflected in the self assessment of treatment questionnaire?

# of participants

# of treatments

Anticonvulsant or anti-seizure medications

Antidepressant medications

Opioid medications

Non-Opioid Analgesic medications

Topical treatments

Qutenza patch

Total

95

32

15

11

14

8

10

N=44

 

(73%)

(34%)

(25%)

(32%)

(18%)

(23%)

PHN

23

5

3

4

1

5

2

N=8

 

(63%)

(38%)

(50%)

(13%)

(63%)

(25%)

PDPN

42

16

9

5

7

2

1 1

N=20

 

(80%)

(45%)

(25%)

(35%)

(10%)

(5%)

HIV-AN

30

11

3

3

6

1

7

N=16

 

(69%)

(19%)

(19%)

(38%)

(6%)

(44%)

  1. 1One PDPN participant was previous treated with Qutenza but did not recall the treatment. Therefore, this participant was not asked about the treatment experience.